Abstract:The risk of developing Alzheimer's disease (AD) is almost double in patients with insulin resistance. Prolong hyperinsulinemia is a major cause of insulin resistance. We presented in last year that peripheral hyperinsulinemia and insulin resistance alters the biology and function in neurons at early stages. Mechanistically, we showed that failure of prompt glucose metabolism due to loss of hexokinase-2 (HK2) impairs a multi-step pathway that results in reactivation of cell cycle machinery, as well as accumulation of signals of phosphorylated tau and amyloid. Despite all these cellular findings, it is important to address these series of events in vivo, and their consequences on animal behavior. Assays including behavioral analyses in young (3-month) versus aged (22-44 month) wild type mice (N=24) were performed. Stereotaxic injections of adeno-associated virus (AAV) that carries shRNA against HK2 were performed in hippocampal CA1 region of young non-insulin resistant wildtype mice. Behavioral, immunohistochemistry and a variety of cellular and biochemistry methods were performed to analyze changes occurred in these animals. Here we report that insulin resistant neurons eventually become senescent, a consequence of aberrant reactivation of cell cycle machinery. At behavioral level, insulin resistant animals showed cognitive decline and memory impairment, both were inter-correlated to the severity of peripheral insulin resistance and the senescent load in the brain. Mechanistically, the importance of neuronal glycolysis was validated in vivo. Similar behavioral changes were recapitulated in young non-insulin resistant animals with HK2 knockdown in CA1 neurons. Notably, these neurons also showed aberrant cell cycle re-activation and expressed a senescent phenotype. These findings therefore extended our understanding on how peripheral hyperinsulinemia and insulin resistance alters the biology and function of the brain, particularly at behavioral levels. At basic science level, our data also offer a mechanism on how post-mitotic neurons could become senescent—an outcome of aberrant cell cycle reactivation. At translational level, this study re-emphasizes that metabolic syndrome like peripheral insulin resistance is a modifiable risk factor for AD. Better management of insulin resistance is therefore a important strategy to prevent related neurodegeneration events and potential initiation of AD.

Influence of Human Amylin on the Membrane Stability of Rat Primary Hippocampal Neurons.

Changes In Mitochondrial Dynamics During Amyloid Beta-Induced Pc12 Cell Apoptosis

Sub-Toxic Human Amylin Fragment Concentrations Promote the Survival and Proliferation of SH-SY5Y Cells via the Release of VEGF and HspB5 from Endothelial RBE4 Cells

Murine Beta-Amyloid (1–42) Oligomers Disrupt Endothelial Barrier Integrity and VEGFR Signaling via Activating Astrocytes to Release Deleterious Soluble Factors

Hydroxyurea-induced membrane fluidity decreasing as a characterization of neuronal membrane aging in Alzheimer's disease

Impact of Alternating Amino Acid Sequences on Beta-Amyloid-induced Neurotoxicity and Neuroinflammation in Alzheimer's Disease.

Fibrillogenic Amylin Evokes the Apoptosis of Human Mesangial Cells

Amyloid β Oligomers Increase ER-Mitochondria Ca2+ Cross Talk in Young Hippocampal Neurons and Exacerbate Aging-Induced Intracellular Ca2+ Remodeling

The Co-oligomers of Aβ42 and Human Islet Amyloid Polypeptide Exacerbate Neurotoxicity and Alzheimer-like Pathology at Cellular Level

Molecular Insights into the Oligomerization Dynamics and Conformations of Amyloidogenic and Non-Amyloidogenic Amylin from Discrete Molecular Dynamics Simulations

Acute Impairment of Mitochondrial Trafficking by Beta-Amyloid Peptides in Hippocampal Neurons

Study of Neuronal Apoptosis and Changes in Expression of the Proteins Related to the Mitochondrial Pathway after Aβ<sub>1–42</sub> Injection in the Rat Hippocampus

Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin

High-Fat Diet Increases Amylin Accumulation in the Hippocampus and Accelerates Brain Aging in hIAPP Transgenic Mice

Amylin Induces Apoptosis of Cultured Human Mesangial Cells

Changes in hippocampal volume, synaptic plasticity and amylin sensitivity in an animal model of type 2 diabetes are associated with increased vulnerability to amyloid-beta in advancing age

Endogenously Generated Amyloid Β Increases Membrane Fluidity in Neural 2a Cells

Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?

Cytotoxic role of advanced glycation end-products in PC12 cells treated with β‑amyloid peptide.

INSULIN RESISTANT NEURONS ARISEN FROM PERIPHERAL HYPERINSULINEMIA ARE SENESCENT AND CORRELATE WITH MEMORY IMPAIRMENT AND COGNITIVE DECLINE: IMPLICATIONS FOR ALZHEIMER’S DISEASE

Adsorption and Orientation of Human Islet Amyloid Polypeptide (hIAPP) Monomer at Anionic Lipid Bilayers: Implications for Membrane-Mediated Aggregation